Non–Small Cell Lung Cancer: Other Actionable Mutations
2 Pogledi
• 07/04/23
0
0
Ugraditi
administrator
Pretplatnici
Corey J. Langer, MD; V****iliki Papadimitrakopoulou, MD; and Hossein Borghaei, DO, elucidate the potential value of less common actionable mutations in determining appropriate treatment for patients with non–small cell lung cancer.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari